Evidence map›Paper›PMID 38007416›Full record

ArticleBMC infectious diseases2023

Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience.

Mohamed Zakaria Bouayed, Ilyass Laaribi, Iliass Benaini, Asmae Yeznasni, Sara Berrajaa, Younes Oujidi, Houssam Bkiyar, Naima Abda, Brahim Housni

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mohamed Zakaria BouayedAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco. medzakaria.95@gmail.com.
Ilyass LaaribiAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Iliass BenainiAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Asmae YeznasniLaboratory of Epidemiology, Clinical Research and Public Health (LERCSP), Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Sara BerrajaaAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Younes OujidiAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Houssam BkiyarAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Naima AbdaLaboratory of Epidemiology, Clinical Research and Public Health (LERCSP), Faculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Brahim HousniAnesthesia, Intensive Care and Resuscitation Department, Mohammed VI University Hospital of Oujda, Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 induced cytokine storm is a well-documented phenomena that contributes significantly in the disease's evolution and prognosis. Therefore, therapies such as therapeutic plasma exchange, constitute a mainstay of therapeutic management especially for critically-ill patients.

methodsWe conducted a monocentric retrospective cohort study in the Resuscitation Department of the Mohammed VI University Hospital of Oujda-Morocco, to evaluate the efficiency of therapeutic plasma exchange on critically-ill COVID-19 patients over a 6 months period. We divided our patients into two groups: patients who received TPE (Therapeutic Plasma Exchange) sessions (TPE group) and patients who only benefited from the standard protocol treatment (non TPE group).

resultsOur study included a total of 165 patients, 34.5% of which benefited from TPE sessions. We observed an improvement of oxygenation parameters (SpO2 and PaO2/FiO2 ratio) and a progressive respiratory weaning, as well as a significant decrease of biomarkers indicative of inflammation (lymphocyte count, CRP (C Reactive Protein), IL-6, Ferritin) and coagulopathy (d-dimers, fibrinogen) in the TPE group after 5 consecutive TPE sessions. In comparison with the non-TPE group, The TPE-group patients had a shorter ICU (Intensive Care Unit) length of stay, required less frequently mechanical ventilation, and we more likely to be extubated. Furthermore, the TPE group had a lower mortality rate. DISCUSSION: Multiple studies have reported the safety and efficiency of therapeutic plasma exchange in the COVID-19 induced cytokine storm. Given the urgent character of the pandemic at the time, each center followed its own protocol in implementing plasma exchange.

conclusionSimilar to the results reported in the literature, our study reports positive results after using TPE specifically in terms of respiratory weaning and an improvement of the cytokine storm biomarkers, and more importantly a lower mortality rate.

Indexed as

COVID-19BiomarkersCritical IllnessCytokine Release SyndromeHumansPlasma ExchangeRetrospective StudiesSARS-CoV-2BiomarkersCOVID-19Cytokine stormIntensive careMortalityTherapeutic plasma exchange

Identifiers

PMID38007416
PMCPMC10676591
OpenAlexW4389002824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.